Aeterna Zentaris Inc. (AEZS)
NASDAQ: AEZS · IEX Real-Time Price · USD
5.37
-0.61 (-10.20%)
Jul 22, 2024, 9:43 AM EDT - Market open
Aeterna Zentaris Employees
Aeterna Zentaris had 12 employees as of December 31, 2020. The number of employees decreased by 44 or -78.57% compared to the previous year.
Employees
12
Change
-44
Growth
-78.57%
Revenue / Employee
$197,833
Profits / Employee
-$1,504,167
Market Cap
17.91M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2020 | 12 | -44 | -78.57% |
| Dec 31, 2014 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| VBI Vaccines | 138 |
| Lyra Therapeutics | 88 |
| Aspira Women's Health | 64 |
| Biotricity | 55 |
| GlycoMimetics | 35 |
| iBio, Inc. | 26 |
| Indaptus Therapeutics | 7 |
| Synlogic | 6 |
AEZS News
- 5 days ago - Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders - GlobeNewsWire
- 5 weeks ago - Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - GlobeNewsWire
- 6 weeks ago - Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders - PRNewsWire
- 7 weeks ago - Aeterna Zentaris and Ceapro Complete Merger Transaction - GlobeNewsWire
- 7 weeks ago - Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date - GlobeNewsWire
- 2 months ago - Aeterna Zentaris Announces Details Regarding Transaction with Ceapro - GlobeNewsWire
- 2 months ago - Aeterna Zentaris Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Aeterna Zentaris Announces Effective Date of Share Consolidation - GlobeNewsWire